COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 726: Articles 7251-7260  | Next

Virtual care use among older immigrant adults in Ontario, Canada during the COVID-19 pandemic: a repeated cross-sectional analysis
Brual, J., Chu, C., Fang, J., Fleury, C., Stamenova, V., Bhattacharyya, O., Tadrous, M.
10.1101/2022.07.20.22277848 — Posted: 2022-07-26
#LongCOVID affects children too: A Twitter analysis of healthcare workers sentiment and discourse about Long COVID in children and young people in the UK
Martin, S., Chepo, M., Deom, N., Khalid, A. F., Vindrola-Padros, C.
10.1101/2022.07.20.22277865 — Posted: 2022-07-25
SARS-CoV-2 BA.5 vaccine breakthrough risk and severity compared with BA.2: a case-case and cohort study using Electronic Health Records in Portugal
Kislaya, I., Casaca, P., Borges, V., Sousa, C., Ferreira, B., Fernandes, E., Matias Dias, C., Duarte, S., Almeida, J. P., Coelho, L., Grenho, I., Ferreira, R., Pita Ferreira, P., Isidro, J., Pinto, M., Menezes, L., Sobral, D., Nunes, A., Santos, D., Maia Goncalves, A., Vieira, L., Gomes, J. P., Pinto Leite, P., Nunes, B., Machado, A., Peralta Santos, A.
10.1101/2022.07.25.22277996 — Posted: 2022-07-25
Lowered quality of life in Long COVID is strongly predicted by affective symptoms and chronic fatigue syndrome which are associated with inflammatory processes during the acute infectious phase and consequent neuroimmunotoxic pathways.
Maes, M., Tahseen Al-Rubaye, H., Almulla, A. F., Shihab Al-Hadrawi, D., Stoyanova, K., Kubera, M., Al-Hakeim, H. K.
10.1101/2022.07.25.22277980 — Posted: 2022-07-25
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer and coronary disease pathways
Cruchaga, C., Wang, L., Sung, Y. J., Western, D., Timsina, J., Repaci, C., Song, W.-M., Norton, J., Kohlfeld, P., Budde, J., Climer, S., Bbut, O. H., Jacobson, D. A., Garvin, M. R., Templeton, A. R., Campagna, S., O'Halloran, J., Presti, R., Goss, C. W., Mudd, P. A., Ances, B. M., Zhang, B.
10.1101/2022.07.25.22278025 — Posted: 2022-07-25
Beta-Thalassemia minor and SARS-CoV-2, prevalence, severity, morbidity and mortality: a systematic review study
Lansiaux, E., Drouin, E., Bolm, C.
10.1101/2022.07.25.22278009 — Posted: 2022-07-25
Transfer learning for Covid-19 detection in medical images
El Azhari, M.
10.1101/2022.07.25.22278017 — Posted: 2022-07-25
SARS-CoV-2 omicron variants succumb in vitro to Artemisia annua hot water extracts
Nair, M. S., Huang, Y., Weathers, P.
10.1101/2022.07.22.501141 — Posted: 2022-07-25
Determining the antiviral activity of two polyene macrolide antibiotics following treatment in Kidney Cells infected with SARS-CoV-2
Wasan, K. M., Galliano, C.
10.1101/2022.07.23.501242 — Posted: 2022-07-25
Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans
Moyles, I. R., Heffernan, J. M., Korosec, C. S.
10.1101/2022.07.25.22278031 — Posted: 2022-07-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).